Enter a job title or keyword

Senior Research Associate, Cellular Immunology ( 6 Month Contract)


Job Location:

Boston, MA - USA

Monthly Salary: Not provided by the employer
Posted: 3 July 2026 (30+ days ago)
Application Deadline: 30 September 2026
Vacancies: 1 Vacancy

Job Summary

Overview

Monte Rosa Therapeutics is seeking an energetic and highly motivated Contractor located in Boston to support the development and characterization of novel molecular glue degraders for the treatment of inflammatory diseases. As part of the Immunology and Preclinical Pharmacology team this role will broadly support multiple immunology and inflammation (I&I) projects/programs from early lead optimization through clinical-stage.

The ideal candidate is an experienced experimentalist with a strong background in I&I and a demonstrated ability to work collaboratively to achieve team/company goals.

Responsibilities
  • Design optimize and execute experiments using a variety of primary immune cells and tissues isolated from human mouse or cynomolgus monkey (including PBMCs monocyte-derived macrophages whole blood synovial fluid peritoneal fluid etc.)
  • Routine profiling of compounds using Meso Scale Discovery (MSD) ELISA Western blot Simple Western (Jess) flow cytometry qPCR assays
  • Ex vivo mouse tissue processing (spleen bone marrow lymph node etc.)
  • Maintain timely and detailed notes using electronic lab notebook
Qualifications
  • MS or PhD equivalent in Immunology or Cell Biology with 3 years of hands-on experience in I&I drug discovery research in a pharmaceutical setting
  • Extensive experience handling whole blood primary immune cells and tissue (preferably including clinical samples)
  • Expert in protein detection/quantitation methodology (e.g. MSD ELISA Western blotting Jess)
  • Flow cytometry expertise is preferred
  • Highly proficient with Microsoft Excel GraphPad Prism (FlowJo is preferred)

Required Experience:

Senior IC


About Company

Company Logo

Pioneering Therapies for Cancer and Beyond – Our drug discovery platform is tailored to promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, undruggable proteins, in essence leading to pharmacological protein knockout with high efficiency ... View more

View Profile View Profile